Related by context. Frequent words. (Click for all words.) 84 diagnosed GBM 76 diagnosed multiple myeloma 74 diagnosed Ph + 61 HER2 positive metastatic breast 59 recurrent glioblastoma 59 deforolimus 58 superficial bladder cancer 58 phase IIb clinical 58 Amrubicin 58 metastatic hormone refractory 58 Phase Ib II 57 angiogenesis inhibitor 57 metastatic liver 57 advanced carcinoid 57 phase IIa 57 Allovectin 7 ® 57 metastatic renal cell carcinoma 57 phase Ib 56 bevacizumab Avastin 56 multicenter Phase 56 mRCC 56 diagnosed 56 Phase IIb trials 56 pancreatic adenocarcinoma 56 sliced silicon wafers 56 Zolinza 56 Proxinium TM 56 TTR amyloidosis 56 indolent NHL 55 neoadjuvant therapy 55 administered subcutaneously 55 KRAS wild 55 resectable 55 Phase Ib clinical 55 IV metastatic melanoma 55 multiple myeloma MM 55 refractory chronic lymphocytic 55 relapsing multiple sclerosis 55 malignant pleural mesothelioma 55 metastatic RCC 55 chemoradiotherapy 55 glioblastoma multiforme GBM 55 colorectal carcinoma 55 heavily pretreated 55 axitinib 55 IV melanoma 55 AEG# 55 phase IIa clinical 54 pertuzumab 54 ongoing Phase 1b 54 sunitinib malate 54 vismodegib 54 primary peritoneal 54 colorectal lung 54 gastrointestinal stromal tumors 54 grade gliomas 54 liver transplant recipients 54 docetaxel chemotherapy 54 trabectedin 54 cutaneous melanoma 54 grade glioma 54 bosutinib 54 RRMS patients 54 Phase Ia 54 unresectable 54 renal tumors 54 acute myelogenous leukemia AML 54 Voreloxin 53 hepatocellular cancer 53 relapsed multiple myeloma 53 metastatic castration resistant 53 cell acute lymphoblastic 53 granted Orphan Drug 53 metastatic bone 53 nasopharyngeal cancer 53 randomized #:# 53 prospectively defined 53 Alzhemed TM 53 gastrointestinal stromal tumors GIST 53 allogeneic stem cell 53 heavily pretreated patients 53 resected 53 chronic HCV 53 recurrent prostate cancer 53 breast carcinoma 53 IBS C 53 CMV infection 52 castrate resistant prostate cancer 52 Phase 1b clinical 52 metastatic lung cancer 52 multicenter prospective 52 bone metastasis 52 Metastatic Melanoma 52 lanthanum carbonate 52 neoadjuvant chemotherapy 52 vascular disrupting agent 52 leukaemias 52 recurrent ovarian cancer 52 HNSCC 52 lymphoma CTCL 52 pazopanib